EthAum Zero BS Healthcare Revenue Scaler Program
Check your eligibility
Create a free account and we'll tell you whether your startup qualifies for this grant.
Quick Answer
A 16-week hybrid accelerator by EthAum helping post-prototype healthcare startups globally secure pilots, drive revenue, and attract investment with up to $2M SAFE.
- Funding amount
- Up to ₹16.6 Cr
- Funding type
- Equity
- Provider
- EthAum Venture Partners
- Application deadline
- Rolling
- Location
- International
About this funding program
The EthAum Zero BS Healthcare Revenue Scaler Program is a meticulously designed 16-week hybrid accelerator aimed at transforming post-prototype healthcare and medical AI startups into revenue-generating, investment-ready enterprises. This program, underpinned by EthAum's extensive global healthcare ecosystem, focuses on providing startups with the essential tools, connections, and support needed to scale rapidly. Participants gain unparalleled access to enterprise customers, crucial hospital pilot opportunities, strategic partnerships, and a vast network of investors across key markets including Singapore, India, Japan, Hong Kong, the Middle East, and the UK.
The core objective is to accelerate market entry and revenue growth for innovative healthcare technologies. EthAum's unique "Zero BS" approach emphasizes tangible results, measurable outcomes, and direct GTM (Go-To-Market) support. Beyond the initial 16-week intensive phase, selected startups benefit from an extended four-year post-program ecosystem support, ensuring long-term guidance for customer acquisition, market penetration, and sustained growth. This includes continuous mentorship, introductions to a global investor base, CXOs, channel partners, and healthcare alliances. The program leverages various GTM activities like roadshows, webinars, and specialized 'startup roast sessions' to refine strategies and enhance market readiness.
EthAum, a deep tech revenue scaler and fund based in Singapore, brings a proven track record with over 120 portfolio startups. While sector-agnostic at the fund level, this specific program is dedicated to high-impact innovations within the healthcare sector, including Medical AI, Hospital Digitalization, Life Sciences, and Surgery. The program is ideal for startups seeking to raise between USD 500K–1M and demonstrate monthly revenues from USD 10K to USD 500K, positioning them for significant Series A rounds.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Create a free account to view.
Funding providers
EthAum is a Deep Tech Revenue Scaler and fund based in Singapore with 120+ portfolio startups across sectors including BFSI, Industry 5.0, ESG, PropTech, Gen AI, Security, Retail and Supply Chain. EthAum runs sector-focused revenue-scaler accelerator programs (such as the Zero…
Learn moreBenefits & Funding
- Amount
- Up to ₹16.6 Cr
What You Get
Selected startups receive a SAFE investment of up to USD 2 Million (approx. ₹16.6 Crore), providing significant capital for growth without immediate valuation concerns. Additionally, companies are eligible for pilot funding of up to USD 50,000 (approx. ₹41.5 Lakh) to facilitate initial hospital and enterprise pilots. Beyond direct funding, the program offers a 16-week hybrid accelerator experience followed by an extensive four years of post-program ecosystem support, including expert mentorship, customer acquisition strategies, market access facilitation, and invaluable investor introductions across a global healthcare network.
- Disbursement
- Tranched
- Duration
- 4 months
- Cohort size
- 20 startups
Timelines & Process
Applications
Rolling basis
Selection Process
Applications undergo a rigorous review by the EthAum team, comprising venture associates, managing partners, and venture analysts. The initial screening focuses on evaluating the startup's alignment with the healthcare and medical AI focus, its stage (post-prototype, user traction, or paying customers), revenue metrics, and overall potential for global scalability. Shortlisted startups are then typically invited for deeper engagement, which may include interviews, detailed presentations of their solution, and discussions with EthAum's network of healthcare and GTM experts. The final selection prioritizes companies demonstrating strong innovation, market fit, a capable team, and a clear path to leveraging the EthAum global ecosystem for significant revenue growth and investment attraction.
Application Process
- 1
Application Submission
Applicants submit their detailed applications via the official program portal, including pitch deck and company details.
You - 2
- 3
- 4
- 5
- 6
How to apply
Four steps from draft to disbursement — one action each.
- 1
Draft your application
Answer the form inside the grant tracker — AI drafts each response using your past answers, so you're not starting from a blank page.
- 2
Submit on the official portal
Use the official application link and verify all details before final submission.
- 3
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Frequently Asked Questions
What kind of funding does the program provide?
The program offers a SAFE (Simple Agreement for Future Equity) investment of up to USD 2 Million per startup, along with pilot funding of up to USD 50,000 to facilitate initial trials with healthcare organizations. This is an equity-based investment, with EthAum typically taking 1-10% equity.
What is the duration of the program and the support period?
The core accelerator program runs for 16 weeks in a hybrid format. Beyond this, selected startups benefit from an extended four years of post-program ecosystem support, focusing on continued GTM, customer acquisition, and investor engagement.
Which stages and sectors are eligible?
The program targets incorporated startups at the product (post-prototype with user traction) to early revenue stages (paying customers), typically between Angel and Series A funding rounds. Eligible sectors include Healthcare, Medical AI, Hospital Digitalization, Life Sciences, Surgery, Hospital Operations, and related technologies leveraging Artificial Intelligence or Augmented Reality.
What are the revenue requirements for applicants?
Applicants are expected to have a monthly revenue between USD 10,000 (approx. ₹8.3 Lakh) and USD 500,000 (approx. ₹4.15 Crore) to be considered for the program.
Is the program open to international startups?
Yes, the program has a global reach and is open to startups from India, Singapore, Japan, Taiwan, the United Kingdom, and the Middle East. EthAum Venture Partners is based in Singapore.
What kind of support can startups expect beyond funding?
Startups receive comprehensive GTM support, mentorship from healthcare and GTM experts, pilot opportunities with major hospitals, customer acquisition strategies, access to a vast network of investors and industry CXOs, and participation in roadshows, webinars, and startup roast sessions designed to refine their business and fundraising strategies.
Sources
Data on this page is compiled from official program and provider references.
